MK-8245
Catalog No. A11403
MK-8245是肝脏靶向的硬脂酰CoA去饱和酶(SCD)抑制剂。MK-8245可用于治疗糖尿病和血脂异常。
- Miyayama Y, .et al. Comparative study on the replication of HCV1b genome between wild type and cell culture adaptive mutant in regard to sensitivities against anti-HCV drugs, Microbiol Immunol, 2019, Dec 19 PMID: 31854467
Catalog Num | A11403 |
---|---|
M. Wt | 467.3 |
Formula | C17H16BrFN6O4 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1030612-90-8, 1030612-87-3 |
Synonyms | MK8245 |
SMILES | C1CN(CCC1OC2=C(C=CC(=C2)F)Br)C3=NOC(=C3)C4=NN(N=N4)CC(=O)O |
MK-8245是肝脏靶向的硬脂酰CoA去饱和酶(SCD)抑制剂。MK-8245可用于治疗糖尿病和血脂异常。
Targets
SCD1 (human) | SCD1 (rat) | SCD1 (mouse) | ||
1 nM | 3 nM | 3 nM |
In vitro (25°C) | DMSO | 89 mg/mL (190.47 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% CMC+0.5% Tween-80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.4 mL | 107 mL | 214 mL |
0.5 mM | 4.28 mL | 21.4 mL | 42.8 mL |
1 mM | 2.14 mL | 10.7 mL | 21.4 mL |
5 mM | 0.43 mL | 2.14 mL | 4.28 mL |
*The above data is based on the productmolecular weight 467.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.